Viewed in isolation, perhaps. I note that all the biotechs I'm in and watching are on the nose a bit. I'm also cautious of American, Japanese, and British sovereign debt causing macro pessimism in the coming months - the Australian bourse has not followed the US ones up so high since December, and that could cause a sharp reaction to any negative shocks.
